These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 9029014)

  • 1. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
    Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].
    van den Oudenrijn S; Bruin M; de Haas M; von dem Borne AE
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):469-71. PubMed ID: 11913111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT).
    Tonelli R; Scardovi AL; Pession A; Strippoli P; Bonsi L; Vitale L; Prete A; Locatelli F; Bagnara GP; Paolucci G
    Hum Genet; 2000 Sep; 107(3):225-33. PubMed ID: 11071383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia.
    van den Oudenrijn S; Bruin M; Folman CC; Bussel J; de Haas M; von dem Borne AE
    Br J Haematol; 2002 May; 117(2):390-8. PubMed ID: 11972523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia.
    van den Oudenrijn S; Bruin M; Folman CC; Peters M; Faulkner LB; de Haas M; von dem Borne AE
    Br J Haematol; 2000 Aug; 110(2):441-8. PubMed ID: 10971406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Krukemeier S; Welte K
    Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
    Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
    Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
    Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
    Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
    Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
    Germeshausen M; Ballmaier M; Welte K
    Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
    Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
    Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
    Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
    Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
    Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
    Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis.
    Deng B; Banu N; Malloy B; Hass P; Wang JF; Cavacini L; Eaton D; Avraham H
    Blood; 1998 Sep; 92(6):1981-8. PubMed ID: 9731056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
    Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J
    Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development.
    Basch RS; Zhang XM; Dolzhanskiy A; Karpatkin S
    Br J Haematol; 1999 Jun; 105(4):1044-54. PubMed ID: 10554819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.